Kiora Pharmaceuticals Inc
KPHMW- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesKPRX
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding KPHMW, Q2 2026
No superinvestor reported holding KPHMW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Kiora Pharmaceuticals Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 (view filing) | Sep 11 | 1 day | Stengone Carmine N.Director | PPurchase | +1.25K | $3.68 | +$4.60K | New position1.25K after | |
| Sep 11, 2024 (view filing) | Sep 10 | 1 day | Shapiro AronDirector | PPurchase | +3.00K | $3.60 | +$10.8K | New position3.00K after | |
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Walters-Hoffert LisaDirector | PPurchase | +1.25K | $3.86 | +$4.83K | New position1.25K after | |
| Aug 19, 2024 (view filing) | Aug 19 | Same day | Tyle PraveenDirector | PPurchase | +5.00K | $3.96 | +$19.8K | +35,714.3%5.01K after | |
| Aug 15, 2024 (view filing) | Aug 14 | 1 day | Tosca MelissaCFO | PPurchase | +2.00K | $3.21 | +$6.42K | +17.2%13.6K after | |
| Jun 14, 2024 (view filing) | Jun 14 | Same day | Tosca MelissaEVP Finance | PPurchase | +100 | $5.25 | +$525 | +2.6%3.98K after | |
| Jun 14, 2024 (view filing) | Jun 14 | Same day | Daniels Eric JosephChief Development Officer | PPurchase | +1.43K | $5.29 | +$7.57K | +14.6%11.2K after | |
| Jun 13, 2024 (view filing) | Jun 13 | Same day | Parsons ErinDirector | PPurchase | +5.26K | $4.88 | +$25.7K | New position5.26K after | |
| Jun 13, 2024 (view filing) | Jun 13 | Same day | Strem Brian M.President and CEO | PPurchase | +3.00K | $5.00 | +$15.0K | +26.0%14.5K after | |
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Strem Brian M.President and CEO | PPurchase | +17.9K | $1.41 | +$25.2K | +187.6%27.4K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Kiora Pharmaceuticals Inc at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding KPHMW in 13F filings for Q2 2026.